Lynx1 Capital Management LP 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
LC Lynx1 Capital Management LP | Institutional Filer | ▲ 28.08% | $632.7M | 23 |
Current Portfolio Holdings
Showing all 23 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | STOK | Stoke Therapeutics, Inc. | Healthcare | 4.8M | $155.1M | 24.51% |
| 2 | GHRS | GH Research PLC | Healthcare | 10.8M | $151.3M | 23.92% |
| 3 | CGEM | Cullinan Therapeutics, Inc. | Healthcare | 9.0M | $127.4M | 20.13% |
| 4 | AGIO | Agios Pharmaceuticals, Inc. | Healthcare | 2.6M | $88.3M | 13.96% |
| 5 | DNLI | Denali Therapeutics Inc. | Healthcare | 1.9M | $36.1M | 5.71% |
| 6 | CCCC | C4 Therapeutics, Inc. | Healthcare | 7.0M | $18.4M | 2.91% |
| 7 | KRRO | Korro Bio, Inc. | Healthcare | 1.5M | $17.4M | 2.75% |
| 8 | TCRX | TScan Therapeutics, Inc. | Healthcare | 8.0M | $8.1M | 1.28% |
| 9 | XNCR | Xencor, Inc. | Healthcare | 536K | $6.5M | 1.02% |
| 10 | DTIL | Precision BioSciences, Inc. | Healthcare | 985K | $5.4M | 0.86% |
| 11 | PASG | Passage Bio, Inc. | Healthcare | 624K | $4.9M | 0.77% |
| 12 | NEUP | Neuphoria Therapeutics Inc. | Healthcare | 875K | $3.6M | 0.56% |
| 13 | TRDA | Entrada Therapeutics, Inc. | Healthcare | 212K | $2.7M | 0.42% |
| 14 | CGON | CG Oncology, Inc. Common stock | Healthcare | 32K | $2.1M | 0.34% |
| 15 | IMTX | Immatics N.V. | Healthcare | 217K | $2.1M | 0.34% |
Showing 1 to 15 of 23 holdings